The Rewrite Cancer Innovation Challenge:
How can we facilitate better knowledge transfer and collaboration between multi-disciplinary healthcare teams to improve the continuity of care for patients in an environment where new treatment approaches are fundamentally shifting how patients live with their cancer?
Your ideas could help improve the cancer experience
One winning submission from each of the four categories outlined below may have the opportunity to further develop their ideas with a benefit of funds or in-kind services of up to a maximum value of $50,000 CAD. This benefit can include non-clinical research support and partnerships with policy experts, advocacy groups and medical professionals.
How it Works
Teams will collaborate to discuss, brainstorm, rethink and offer a solution to the Challenge, and help rewrite the story of cancer for tomorrow’s patients.
Each team’s submission must fit in to one of four categories:
- Non-Clinical Research
- Patient Support
- Health Policy
- Medical Education
Please see the Rewrite Cancer Innovation Challenge Official Rules and Regulations for further details on each of these categories.
- Be written in the English language
- Be no more than 1,000 words in length
- Come in the form of a PDF (up to 20MB)
Include the following information:
- Team name
- Team leader’s name and email address
- Team members’ names and email addresses
- Company, institution or organization team represents (if applicable)
- Submission category
Two supplemental files, such as photos (PNG or JPG up to 10MB per photo) and videos (MP4 up to 1GB), may also accompany submissions.
Each team can ask the Steering Committee up to two questions to help guide the development of their submission. The Steering Committee will review and answer questions submitted. Questions and answers will then be compiled and shared with all registered teams.
Once the Challenge closes, the Steering Committee will review and evaluate all submissions, and choose the winning submission(s) in Spring 2018.
Registration OpensNovember 8, 2017
Submit QuestionsJanuary 12, 2018
Submission DeadlineFebruary 28, 2018
Submissions must have a clear approach that offers an innovative solution to the Challenge. Each submission will be reviewed by the Rewrite Cancer Steering Committee of oncology experts based on the following criteria:
- Clarity of outlined proposal
- Evidence of a well thought out design (e.g. approach, executional considerations, resources, etc.)
- Methods of measuring impact/outcome
- Feasibility and broad applicability
- Innovative thinking
Please see the Rewrite Cancer Innovation Challenge Official Rules and Regulations for full details and weighting on evaluation criteria.
Steering Committee Members
Our steering committee of oncology experts will identify the leading ideas that may help make a difference in the lives of Canadians living with cancer.
- Dr. Sarit AssoulineAssociate Professor of Medicine and Oncology, McGill University Jewish General Hospital
- Dr. John C. BellSenior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute; Professor, Faculty of Medicine, University of Ottawa; Scientific Director, BioCanRx
- Dr. Bernie EiglMedical Oncologist, BC Cancer Agency; Clinical Associate Professor, University of British Columbia
- Dr. Rosalyn JuergensAssociate Professor, Department of Oncology, McMaster University; Adjunct Assistant Professor, Department of Oncology, The Johns Hopkins Medical Institute
- Dr. Raj Satkunasivam*Urologic Oncologist, Odette Cancer Centre; Assistant Professor, Division of Urology, Department of Surgery, University of Toronto
- Dr. Sunil VermaMedical Director, Tom Baker Cancer Centre; Head, Department of Oncology, University of Calgary; Medical Lead, Calgary Cancer Project
*Dr. Satkunasivam contributed to the development of the Rewrite Cancer Innovation Challenge design. Since this website’s launch, Dr. Satkunasivam has taken a new role at Methodist Hospital in Houston.